Evidence for possible role of toll-like receptor 3 mediating virus-induced progression of pituitary adenomas

Molecular and Cellular Endocrinology

Volumn 426, Issue , 2016, Pages 22-32

  Zheng, Xin ^a   Li, Song ^a   Zang, Zhenle ^a   Hu, Jintao ^a   An, Jiayin ^a   Pei, Xiangdong ^a   Zhu, Feng ^c   Zhang, Weihua ^b   Yang, Hui ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b University of Houston   (United States)

^c CHONGQING UNIVERSITY   (China)

Author keywords

Pituitary adenoma; Progression; Toll like receptor 3; Viruses

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TOLL LIKE RECEPTOR 3; TLR3 PROTEIN, HUMAN;

ADULT; AGED; ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 6; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONHUMAN; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; TUMOR GROWTH; ADENOMA; ANIMAL; APOPTOSIS; DISEASE COURSE; EXANTHEMA SUBITUM; HYPOPHYSIS TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; VIROLOGY;

ADENOMA; ADULT; AGED; ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE PROGRESSION; FEMALE; HERPESVIRUS 6, HUMAN; HUMAN PAPILLOMAVIRUS 16; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PITUITARY NEOPLASMS; RATS; ROSEOLOVIRUS INFECTIONS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 3;

EID: 84958555032     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2016.02.009     Document Type: Article

References (39)

1. Aflorei E.D., Korbonits M. Epidemiology and etiopathogenesis of pituitary adenomas. J. Neurooncol. 2014, 117:379-394.
2. Amarante M.K., Watanabe M.A.E. Toll-like receptor 3: involvement with exogenous and endogenous RNA. Int. Rev. Immunol. 2010, 29:557-573.
3. Bergonzini V., Salata C., Calistri A., Parolin C., Palù G. View and review on viral oncology research. Infect. Agent Cancer 2010, 5:11.
4. Butel J.S. Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease. Carcinogenesis 2000, 21:405-426.
5. Cerwenka A., Lanier L.L. Natural killer cells, viruses and cancer. Nat. Rev. Immunol. 2001, 1:41-49.
6. Chuang H.C., Huang C.C., Chien C.Y., Chuang J.H. Toll-like receptor 3-mediated tumor invasion in head and neck cancer. Oral Oncol. 2012, 48:226-232.
7. Colao A., Grasso L.F.S., Pivonello R., Lombardi G. Therapy of aggressive pituitary tumors. Expert Opin. Pharmacother. 2011, 12:1561-1570.
8. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420:860-867.
9. Di Ieva A., Rotondo F., Syro L.V., Cusimano M.D., Kovacs K. Aggressive pituitary adenomas-diagnosis and emerging treatments. Nat. Rev. Endocrinol. 2014, 10:423-435.
10. Gandour-Edwards R., Kapadia S.B., Janecka I.P., Martinez A.J., Barnes L. Biologic markers of invasive pituitary adenomas involving the sphenoid sinus. Mod. Pathol. 1995, 8:160-164.
11. Huang B., Zhao J., Unkeless J.C., Feng Z.H., Xiong H. TLR signaling by tumor and immune cells: a double-edged sword. Oncogene 2008, 27:218-224.
12. Hussaini I.M., Trotter C., Zhao Y., Abdel-Fattah R., Amos S., Xiao A., Agi C.U., Redpath G.T., Fang Z., Leung G.K.K., Lopes M.B.S., Laws E.R. Matrix metalloproteinase-9 is differentially expressed in nonfunctioning invasive and noninvasive pituitary adenomas and increases invasion in human pituitary adenoma cell line. Am. J. Pathol. 2007, 170:356-365.
13. Karin M., Greten F.R. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 2005, 5:749-759.
14. Kawamoto H., Kawamoto K., Mizoue T., Uozumi T., Arita K., Kurisu K. Matrix metalloproteinase-9 secretion by human pituitary adenomas detected by cell immunoblot analysis. Acta Neurochir. (Wien) 1996, 138:1442-1448.
15. Kawasaki T., Kawai T. Toll-like receptor signaling pathways. Front. Immunol. 2014, 5:461.
16. Knosp E., Steiner E., Kitz K., Matula C. Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 1993, 33:610-617. discussion 617-618.
17. Li Z., Duan Y., Cheng S., Chen Y., Hu Y., Zhang L., He J., Liao Q., Yang L., Sun L.Q. EBV-encoded RNA via TLR3 induces inflammation in nasopharyngeal carcinoma. Oncotarget 2015, 6:24291-24303.
18. Liu W., Matsumoto Y., Okada M., Miyake K., Kunishio K., Kawai N., Tamiya T., Nagao S. Matrix metalloproteinase 2 and 9 expression correlated with cavernous sinus invasion of pituitary adenomas. J. Med. Invest. 2005, 52:151-158.
19. Loutfy S.A., Fawzy M., El-Wakil M., Moneer M.M. Presence of human herpes virus 6 (HHV6) in pediatric lymphomas: impact on clinical course and association with cytomegalovirus infection. Virol. J. 2010, 7:287.
20. Meij B.P., Lopes M.-B.S., Ellegala D.B., Alden T.D., Laws E.R. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery. J. Neurosurg. 2002, 96:195-208.
21. Mete O., Ezzat S., Asa S.L. Biomarkers of aggressive pituitary adenomas. J. Mol. Endocrinol. 2012, 49:R69-R78.
22. Poreba E., Broniarczyk J.K., Gozdzicka-Jozefiak A. Epigenetic mechanisms in virus-induced tumorigenesis. Clin. Epigenetics 2011, 2:233-247.
23. Qiu L., He D., Fan X., Li Z., Liao C., Zhu Y., Wang H. The expression of interleukin (IL)-17 and IL-17 receptor and MMP-9 in human pituitary adenomas. Pituitary 2011, 14:266-275.
24. Qiu L., He D., Fan X., Li Z., Liao C., Zhu Y., Wang H. The expression of interleukin (IL)-17 and IL-17 receptor and MMP-9 in human pituitary adenomas. Pituitary 2011, 14:266-275.
25. Read S.A., Douglas M.W. Virus induced inflammation and cancer development. Cancer Lett. 2014, 345:174-181.
26. Renner U., De Santana E.C., Gerez J., Fröhlich B., Haedo M., Pereda M.P., Onofri C., Stalla G.K., Arzt E. Intrapituitary expression and regulation of the gp130 cytokine interleukin-6 and its implication in pituitary physiology and pathophysiology. Ann. N. Y. Acad. Sci. 2009, 1153:89-97.
27. Saint-Jean M., Knol A.C., Nguyen J.M., Khammari A., Dréno B. TLR expression in human melanoma cells. Eur. J. Dermatol. 2011, 21:899-905.
28. Sauer J., Renner U., Hopfner U., Lange M., Muller A., Strasburger C.J., Pagotto U., Arzt E., Stalla G.K. Interleukin-1 beta enhances interleukin-1 receptor antagonist content in human somatotroph adenoma cell cultures. J. Clin. Endocrinol. Metab. 1998, 83:2429-2434.
29. Scheithauer B.W., Kovacs K.T., Laws E.R., Randall R.V. Pathology of invasive pituitary tumors with special reference to functional classification. J. Neurosurg. 1986, 65:733-744.
30. Scott M.E., Ma Y., Farhat S., Moscicki A.-B. Expression of nucleic acid-sensing toll-like receptors predicts HPV16 clearance associated with an E6-directed cell-mediated response. Int. J. Cancer 2015, 136:2402-2408.
31. Thapar K., Kovacs K., Scheithauer B.W., Stefaneanu L., Horvath E., Pernicone P.J., Murray D., Laws E.R. Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody. Neurosurgery 1996, 38:99-106. discussion 106-107.
32. Thompson M.R., Kaminski J.J., Kurt-Jones E.A., Fitzgerald K.A. Pattern recognition receptors and the innate immune response to viral infection. Viruses 2011, 3:920-940.
33. Turner H.E., Nagy Z., Esiri M.M., Harris A.L., Wass J.A. Role of matrix metalloproteinase 9 in pituitary tumor behavior. J. Clin. Endocrinol. Metab. 2000, 85:2931-2935.
34. Woloschak M., Yu A., Post K.D. Detection of polyomaviral DNA sequences in normal and adenomatous human pituitary tissues using the polymerase chain reaction. Cancer 1995, 76:490-496.
35. Xiao Z., Liu Q., Mao F., Wu J., Lei T. TNFα-induced VEGF and MMP-9 expression promotes hemorrhagic transformation in pituitary adenomas. Int. J. Mol. Sci. 2011, 12:4165-4179.
36. Zhan Z., Xie X., Cao H., Zhou X., Zhang X.D., Fan H., Liu Z. Autophagy facilitates TLR4- and TLR3-triggered migration and invasion of lung cancer cells through the promotion of TRAF6 ubiquitination. Autophagy 2014, 10:257-268.
37. Zhou W., Song Y., Xu H., Zhou K., Zhang W., Chen J., Qin M., Yi H., Gustafsson J.A., Yang H., Fan X. In nonfunctional pituitary adenomas, estrogen receptors and slug contribute to development of invasiveness. J. Clin. Endocrinol. Metab. 2011, 96:E1237-E1245.
38. Zhou K., Jin H., Luo Y. Expression and significance of E-cadherin and β-catenins in pituitary adenoma. Int. J. Surg. Pathol. 2013, 21:363-367.
39. Zhou Q., Zhu K., Cheng H. Toll-like receptors in human papillomavirus infection. Arch. Immunol. Ther. Exp. Warsz. 2013, 61:203-215.